DIPENTUM

olsalazine sodium · Viatris Specialty LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for DIPENTUM, covering 2007-07-10 to 2024-07-30. Get the full timeline:

Most recent: FDA Approved: DIPENTUM — Supplemental Application (Viatris Specialty LLC)